ATE238069T1 - Neue komplexe von taxol oder taxotere und pharmazeutische zusammensetzungen - Google Patents

Neue komplexe von taxol oder taxotere und pharmazeutische zusammensetzungen

Info

Publication number
ATE238069T1
ATE238069T1 AT95936697T AT95936697T ATE238069T1 AT E238069 T1 ATE238069 T1 AT E238069T1 AT 95936697 T AT95936697 T AT 95936697T AT 95936697 T AT95936697 T AT 95936697T AT E238069 T1 ATE238069 T1 AT E238069T1
Authority
AT
Austria
Prior art keywords
taxol
cyclodextrin
taxotere
beta
taxus
Prior art date
Application number
AT95936697T
Other languages
English (en)
Inventor
Lajos Szente
Jozsef Szejili
Andrasne Vikmon
Julianna Szeman
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Application granted granted Critical
Publication of ATE238069T1 publication Critical patent/ATE238069T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Epoxy Compounds (AREA)
AT95936697T 1994-11-11 1995-11-02 Neue komplexe von taxol oder taxotere und pharmazeutische zusammensetzungen ATE238069T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9403237A HUT73844A (en) 1994-11-11 1994-11-11 New taxol complexes and pharmaceutical compositions containing them
PCT/HU1995/000055 WO1996014872A1 (en) 1994-11-11 1995-11-02 Novel complexes and their compositions

Publications (1)

Publication Number Publication Date
ATE238069T1 true ATE238069T1 (de) 2003-05-15

Family

ID=10985749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95936697T ATE238069T1 (de) 1994-11-11 1995-11-02 Neue komplexe von taxol oder taxotere und pharmazeutische zusammensetzungen

Country Status (13)

Country Link
US (1) US6432928B1 (de)
EP (1) EP0788373B1 (de)
JP (1) JPH10508836A (de)
AT (1) ATE238069T1 (de)
AU (1) AU716704B2 (de)
CA (1) CA2205019A1 (de)
DE (1) DE69530502T2 (de)
DK (1) DK0788373T3 (de)
ES (1) ES2201121T3 (de)
HU (1) HUT73844A (de)
IL (1) IL115917A0 (de)
WO (1) WO1996014872A1 (de)
ZA (1) ZA959567B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US8853260B2 (en) * 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
HUP9701945A3 (en) * 1997-11-10 2000-04-28 Hexal Ag Pharmaceutical composition for injection containing cyclodextrin and taxoids
NZ506389A (en) * 1998-02-05 2003-07-25 Novartis Ag Pharmaceutical compositions containing epothilone which can be optionally lyophilised
US5981564A (en) * 1998-07-01 1999-11-09 Universite Laval Water-soluble derivatives of paclitaxel, method for producing same and uses thereof
JP4585074B2 (ja) * 2000-03-28 2010-11-24 ライオン株式会社 薬剤組成物の製造方法
US6759058B1 (en) * 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
US8658202B2 (en) * 2001-04-25 2014-02-25 Western University Of Health Sciences Coated drug delivery formulations
EP1462512B1 (de) * 2003-03-24 2007-08-01 The Procter & Gamble Company Zusammensetzungen enthaltend Cyclodextrinkomplexe und mindestens ein Waschmitteladditiv
US7125833B2 (en) * 2003-03-24 2006-10-24 Wacker Chemie Ag Cyclodextrin laundry detergent additive complexes and compositions containing same
US7157446B2 (en) * 2003-05-02 2007-01-02 Bristol Myers Squibb Company Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
US7266899B2 (en) * 2004-08-18 2007-09-11 Mark Sanders Speed level
US20060105045A1 (en) * 2004-11-08 2006-05-18 Buchanan Charles M Cyclodextrin solubilizers for liquid and semi-solid formulations
KR100917809B1 (ko) * 2006-05-22 2009-09-18 에스케이케미칼주식회사 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물
WO2009155070A2 (en) * 2008-05-30 2009-12-23 Novelix Pharmaceuticals, Inc. Compositions and methods for treatment of inflammation and hyperkeratotic lesions
DE102010023790A1 (de) 2010-06-15 2011-12-15 Heinrich-Heine-Universität Düsseldorf Waschaktive Zusammensetzung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU199444B (en) * 1985-09-10 1990-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 7-isopropoxy-isoflavone-cyclodextrene inclusion complex and pharmaceutical compositions therefrom
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5120720A (en) * 1990-09-20 1992-06-09 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers
JPH0753396A (ja) 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法および用途
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
HU213200B (en) * 1993-05-12 1997-03-28 Chinoin Gyogyszer Es Vegyeszet The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production

Also Published As

Publication number Publication date
CA2205019A1 (en) 1996-05-23
ES2201121T3 (es) 2004-03-16
ZA959567B (en) 1996-05-28
AU716704B2 (en) 2000-03-02
WO1996014872A1 (en) 1996-05-23
DE69530502D1 (de) 2003-05-28
HU9403237D0 (en) 1995-01-30
EP0788373A1 (de) 1997-08-13
JPH10508836A (ja) 1998-09-02
AU3854095A (en) 1996-06-06
IL115917A0 (en) 1996-01-31
US6432928B1 (en) 2002-08-13
DK0788373T3 (da) 2003-08-11
EP0788373B1 (de) 2003-04-23
HUT73844A (en) 1996-09-30
DE69530502T2 (de) 2004-03-04

Similar Documents

Publication Publication Date Title
DE69530502D1 (de) Neue komplexe von taxol oder taxotere und pharmazeutische zusammensetzungen
FI955424A0 (fi) Syklodekstriinien kanssa muodostettuja taksoli- ja taksoteeri- tai Taxus-uuteinkluusiokomplekseja ja niiden valmistus ja käyttö
ITPD20020271A1 (it) Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati.
EA200000494A1 (ru) Фармацевтические композиции, содержащие циклодекстрины и таксоиды
ATE218374T1 (de) Gegenstände mit kleiner cyclodextrinteilchengrösse für geruchskontrolle
FI964285A (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
CY1110449T1 (el) Συνδυασμος δοκεταξελης και φλαβοπιριδinολης
IT1241673B (it) Complessi di inclusione di silibinina con ciclodestrina, loro preparazione e composizioni farmaceutiche che li contengono.
NO994408L (no) Dolastatin-15 derivater i kombinasjon med taxaner
ATE138656T1 (de) Einschlusskomplexe des n-ethoxycarbonyl-3- morpholino-sydnonimins oder seine mit cyclodextrin-derivaten gebildeten salze, herstellung dieser komplexe und pharmazeutische zusammensetzungen, die diese komplexe enthalten
MX9604984A (es) Composiciones farmaceuticas a base de derivados de la clase de los taxanos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0788373

Country of ref document: EP